Partner Network for a Clinically Validated Multi-Analyte Lab-on-a-Chip Platform (PARCIVAL)
Research Areas
At a Glance
- Status: Completed Consortium
- Year Launched: 2012
- Initiating Organization: European Commission Seventh Framework Programme (FP7)
- Initiator Type: Government
- No disease focus
- Location: Europe
Abstract
The objective of Partner Network for a Clinically Validated Multi-Analyte Lab-on-a-Chip Platform (PARCIVAL) is to develop an integrated and automated multi-analyte lab-on-a-disk platform for the fast and reliable “sample in-answer out” diagnosis of highly infectious respiratory pathogens, resistance patterns, and biomarkers for individual severity of the infection.
Mission
The objective of PARCIVAL is to develop an integrated and automated multi-analyte lab-on-a-disk platform for the fast and reliable sample in-answer out diagnosis of highly infectious respiratory pathogens, resistance patterns, and biomarkers for individual severity of the infection. The platform format will be based on completely integrated microfluidic foil-disposables. The disposables will feature different panels (selection of pathogens, resistance patterns, biomarkers), which can be freely selected and combined to allow a comprehensive choice of diagnostic parameters by the clinician at the point-of-care, vastly increasing the access to diagnostic information for doctors in everyday situations and emergencies. The integrated platform with pre-packaged liquid and dry reagents will automate all processing steps from sample preparation to assay processing to result reporting. This will allow evidence-based therapeutic decisions and allow antibiotic prescriptions that are tailored to the individual patient and thus offer the prospect to greatly improve therapeutic outcomes. Also, an air-sampling add-on module for monitoring of clinical ventilation systems will be developed and interfaced to the platform.
Consortium History
The project started on Jan. 1 2012, and lasted for three years.
Structure & Governance
The consortium consists of nine partners (six enterprises, four of which are SMEs, and three institutes).
Sponsors & Partners
PARCIVAL is a project financed by the EC (FP7-HEALTH Collaborative project).
Homepage |
e-mail: info@parcival-project.eu
Erasmus University Medical Centre |
HAHN-Schickard Society for Applied Research |
Institutul National De Cercetaredezvoltare Pentru Microtehnologie |
Medizinisches Versorgungszentrum – Labor Stein (Germany) |
PathoFinder (Netherlands) |
Rohrer Switzerland |
Askion |
Agrobiogen (Germany) |
Germany GMBH EADS |